Effects of Citrus Reticulate Unripe Fruit Extraction on Body Weight and Body Fat.
NCT ID: NCT05620667
Last Updated: 2022-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
300 participants
INTERVENTIONAL
2022-10-28
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults
NCT04910646
Effect of Intake of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Blood Cholesterol.
NCT03332641
Effect of Citrus Flavonoids on Obesity.
NCT06680635
Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss
NCT00692731
Effect of Cherry Juice on Fat Oxidation and Cardio-metabolic Markers
NCT02999256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
Placebo 25mL, without any ingredients of immature ponkan extract. Drink 25mL for once, and once a day.
placebo
Drink 25mL for once, and once a day.
immature ponkan (Citrus reticulate) extract
Immature ponkan (Citrus reticulate) extract 25 mL, drink 25mL for once, and once a day.
immature ponkan (Citrus reticulate) extract
Drink 25mL for once, and once a day.
immature ponkan (Citrus reticulate) extract with time restricted feeding
Immature ponkan (Citrus reticulate) extract 25 mL, drink 25mL for once, and once a day, adding time restricted feeding.
immature ponkan (Citrus reticulate) extract
Drink 25mL for once, and once a day.
time restricted feeding
Controlling a shortened period of time for eating within 8 hour each day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
immature ponkan (Citrus reticulate) extract
Drink 25mL for once, and once a day.
placebo
Drink 25mL for once, and once a day.
time restricted feeding
Controlling a shortened period of time for eating within 8 hour each day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 20-60 years old
* body mass index is greater than or equal to 24 kg/m2, or body fat more than 30%
Exclusion Criteria
* Subjects diagnosed with heart disease and on curative care.
* Subjects who use other drugs whose pharmacological effects may affect the experiment or may aggravate the effects of the drug.
* Subjects with systemic infection requiring antibiotics.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TCI Co., Ltd.
INDUSTRY
Chung Shan Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chin-Lin Hsu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yu-Jou Chien, PhD student
Role: PRINCIPAL_INVESTIGATOR
Chung Shan Medical University
Ying-Ching Feng, MS student
Role: PRINCIPAL_INVESTIGATOR
Chung Shan Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chung Shan Medical University
Taichung, South, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS2-22066
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.